NCT01188252 2017-01-09Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced MalignanciesBayerPhase 1 Completed112 enrolled